In the past number of years, the UK has witnessed a revolution in professional medical fat‑decline treatment options — with the introduction of semaglutide (Wegovy®) to the rising level of popularity of tirzepatide (Mounjaro®). Now, A further title is drawing interest in the two clinical and publ